In partnership with
The Bottom Line Upfront 💡
Marsh & McLennan $MMC ( ▲ 0.51% ) is a wide-moat compounder trading near fair value at ~$177 — a high-quality franchise at a modest discount, not a screaming bargain. The McGriff acquisition added leverage and temporary margin pressure, but the underlying business is as strong as ever. Expect steady, boring, wonderful returns.
Sponsorship
7 External Traffic Strategies. One question finally answered.
What actually moved your BSR?
Most eCommerce brands running external traffic can't answer that. Wrong channels, no real attribution, and at the end of the month, a dashboard full of activity and no proof of what drove revenue.
The brands getting it right aren't spending more. They've just stopped guessing.
They know which channels pull weight on Amazon listings, which ones look good in a report but bleed budget, and why creator and affiliate traffic consistently outperform paid social when it's set up correctly.
Levanta's free playbook breaks down all 7 strategies. Where each one works, where it falls apart, and what it takes to scale without it becoming a second job. If you're serious about moving your BSR without living inside PPC, this is worth 5 minutes.
Strata Layers Chart
Layer 1: The Business Model 🏛️
Think of Marsh & McLennan as the world’s most sophisticated risk middleman. When a Fortune 500 company needs to insure a $2 billion offshore oil platform, they don’t Google “cheap insurance” — they call Marsh. When an insurer needs to protect itself from catastrophic losses, they call Guy Carpenter. When a corporation needs to pay 50,000 employees competitively, they call Mercer. And when a bank needs strategic consulting, they call Oliver Wyman (now Marsh Management Consulting — more on that later).
Two segments, four brands, one giant fee machine:
Risk & Insurance Services (64% of revenue): Marsh Risk (insurance broking) + Guy Carpenter (reinsurance). They earn commissions when they place insurance — typically 10-20% of premiums — plus interest on ~$11.5B in client premiums they hold temporarily. That “fiduciary interest income” alone was $403M in 2025. ↗️
Consulting (36% of revenue): Mercer (HR, benefits, $692B in assets under management) + Marsh Management Consulting (strategy, economics, brand). Mostly fee-based advisory work.
How they measure success internally: Underlying revenue growth (strips out FX and M&A noise), operating margin by segment, and Mercer’s assets under management.
Key Takeaway: MMC gets paid to be the expert in the room — whether placing your insurance, managing your pension, or telling your CEO what to do next.
Layer 2: Category Position 🏆
MMC operates in a cozy oligopoly at the top of global insurance broking. The “Big Three” — Marsh, Aon, and Willis Towers Watson — dominate large commercial insurance placement globally. That’s it. Three companies. If you’re a multinational with complex risks, your options are limited — exactly how MMC likes it.
Competitive advantages that actually matter:
🔒 Sticky clients: Multi-year relationships with high switching costs. You don’t fire your broker mid-policy.
📊 Data moat: Decades of proprietary claims and pricing data smaller competitors can’t replicate.
🌍 Global footprint: 130 countries. Try matching that.
The McGriff move: In November 2024, MMC dropped $7.75B to acquire McGriff Insurance Services, dramatically expanding its U.S. middle-market presence through Marsh McLennan Agency (MMA). MMA has now completed 135+ acquisitions since 2009 — they’ve turned regional agency roll-ups into an art form. ↗️
The threat worth watching: Insurtech platforms and AI-native competitors are nibbling at the simpler end of the market. MMC’s response? Invest in AI (46,000 colleagues trained through their AI Academy) and launch the “Thrive” efficiency program targeting $400M in annualized savings.
Key Takeaway: MMC is a market leader in a structurally consolidated industry — the kind of competitive position that lets you sleep at night.
Layer 3: Show Me The Money! 📈
Revenue breakdown (2025):
Business | Revenue | Growth (Organic) |
|---|---|---|
Marsh Risk | $14.4B | +4% ↗️ |
Guy Carpenter | $2.5B | +5% ↗️ |
Mercer | $6.2B | +4% ↗️ |
Marsh Mgmt Consulting | $3.6B | +6% ↗️ |
Geography: ~49% U.S., ~14% U.K., ~37% rest of world. That international exposure is a double-edged sword — great diversification, but FX headwinds cost ~$104M in revenue translation in 2025. ↘️
Margin story: Risk & Insurance runs at 26.8% operating margin ↘️ (down from 28.4% in 2024 — McGriff integration costs are the culprit). Consulting holds steady at 19.4%. The margin compression is temporary and expected; the underlying business is healthy.
The cost structure: Compensation is ~58% of revenue — this is a people business, full stop. When you sell expertise, your biggest asset walks out the door every evening.
Cash generation is exceptional: $5.3B in operating cash flow in 2025 ↗️, with free cash flow of ~$5.0B. The company returned $3.7B to shareholders via dividends ($1.7B) and buybacks ($2.0B), and authorized a fresh $6B buyback program in November 2025.
One flag: Total debt sits at ~$19.6B (mostly McGriff financing). At ~3.9x EBITDA, it’s manageable but not trivial. Interest expense jumped to $960M in 2025 ↗️ vs. $700M in 2024. They’re paying for that acquisition.
Key Takeaway: MMC is a cash-generating machine with temporarily compressed margins — the McGriff hangover is real but finite.
Layer 4: Long-Term Valuation (DCF Model) 💰
The Verdict: Fairly Valued with Upside Optionality
Scenario | Fair Value | vs. ~$177 Current Price |
|---|---|---|
Conservative | $170 | -7% ↘️ |
Base Case | $211 | +15% ↗️ |
Optimistic | $257 | +41% ↗️ |
Note: DCF uses WACC of 8.05% (base), terminal growth of 3.0%. Base case aligns almost perfectly with independent FMP DCF estimate of $209.96.
Key assumptions driving the numbers:
Organic revenue growth of 4-7.5% annually through 2030
Operating margins expanding modestly to ~23.8-25% as Thrive savings kick in
$400M annualized savings from Thrive fully realized by 2027-2028
One-line take: At ~$177, you’re buying a high-quality franchise at a modest discount to fair value — not a screaming bargain, but not a value trap either.
Layer 5: What Do We Have to Believe? 📚
Bull Case 🚀
McGriff delivers its $400M+ synergy promise and MMA continues its roll-up strategy profitably
Thrive’s $400M in annualized savings flows through to margins, pushing Risk & Insurance operating margins back above 27%
Mercer’s $692B AUM base keeps growing as aging demographics drive pension management demand globally
Bear Case 🐻
A soft insurance market (falling premium rates) directly compresses commission revenue — MMC can’t control what insurers charge
The $19.6B debt load becomes painful if rates stay elevated longer than expected, and McGriff integration stumbles
AI-native competitors or direct insurer distribution erodes the broker’s role in simpler commercial lines over the next decade
The Bottom Line: MMC is the kind of business Warren Buffett would call a “wide moat” — recurring revenue, pricing power, and clients who genuinely need them. The McGriff acquisition added leverage and integration risk, but the underlying franchise is as strong as ever. This isn’t a moonshot; it’s a compounder. Expect steady, boring, wonderful returns. 😴💰
Layer 6: What to Watch 👀
McGriff integration costs — The company expects ~$250M more in retention/integration costs over two years. Watch for this to decline; if it doesn’t, margins stay compressed longer.
Underlying organic revenue growth — Management targets ~4-5%. If this slips below 3% for two consecutive quarters, something structural may be wrong.
Fiduciary interest income — Fell from $497M (2024) to $403M (2025) ↘️ as rates declined. This is essentially free money that disappears in a low-rate environment.
Greensill litigation — Trial is scheduled for August 2026 in Australia. The company can’t estimate potential losses. A genuine wildcard. 🎲
Thrive program savings — $400M annualized savings expected over three years. Watch for management to quantify realized savings on earnings calls. If they go quiet, be skeptical.
AI-written, human-approved
Disclaimer: This guide is for informational purposes only and does not constitute financial advice, investment recommendations, or an offer or solicitation to buy or sell any securities. The information contained in this report has been obtained from sources believed to be reliable, but StrataFinance does not guarantee its accuracy, completeness, or timeliness.